Comparative Pharmacology
Head-to-head clinical analysis: FEXINIDAZOLE versus SATRIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FEXINIDAZOLE versus SATRIC.
FEXINIDAZOLE vs SATRIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fexinidazole is a nitroimidazole derivative that enters the parasite and inhibits DNA synthesis by forming reactive metabolites, leading to cell death. It is active against Trypanosoma brucei gambiense.
SATRIC is a combination of sulfathiazole, sulfacetamide, and sulfabenzamide, which are sulfonamide antibiotics. They competitively inhibit dihydropteroate synthase, blocking folate synthesis in susceptible bacteria.
500 mg orally twice daily for 10 days for trichomoniasis; 2 g orally single dose for giardiasis.
No standard dosing information available for SATRIC.
None Documented
None Documented
Approximately 8-12 hours in adults; prolonged in hepatic impairment.
3-5 hours in healthy adults; prolonged to 6-8 hours in renal impairment (CrCl < 30 mL/min)
Primarily renal (60-70% unchanged), with 20-30% biliary/fecal.
Renal: 70% unchanged; fecal: 20%; biliary: 10%
Category C
Category C
Antiprotozoal
Antiprotozoal, Antibiotic